Sergio Schuler, head of animal nutrition and health EMEA for DSM-Firmenich, explains how technology can

pension fund ABP and Invest-NL, with additional backing from InnovationQuarter and existing shareholders DSM-Firmenich

A new approach to methane emissions Bovaer, developed by DSM-Firmenich, is designed to be added in small In a statement, DSM-Firmenich said: "As with any supplement, Bovaer has been tested over many years in FoodSafety #FeedAdditives #Farmers #SustainableDairy #ConsumerTrust #AgricultureInnovation #UKFarming #DSM

Royal DSM has launched a textured vegetable protein that contains the necessary levels of all nine essential According to DSM, the solution will help producers create a more realistic and "nutritionally appealing DSM stated that the new ingredient was designed "to offer a complete protein with more of the meat-like Samah Garringer, business unit director, proteins of the future at DSM, said: “It’s an exciting time At the heart of all our initiatives at DSM is looking after people and our planet.

DSM has announced plans to build a new global head office in Maastricht, the Netherlands, which is expected company is moving its head office from its current Heerlen location – which has been the home base of DSM DSM says the new office will be a “true visualisation” of its culture and will reinforce the company’ Meanwhile, DSM revealed that the Sittard office will close permanently. Geraldine Matchett and Dimitri de Vreeze, co-CEOs of DSM, said: “DSM’s new head office is more than a

DSM has expanded its Dairy Safe cheese biopreservation portfolio with a new range of phage-robust culture DSM has added four new culture rotations to the portfolio to offer a more robust system, which it claims Dairy Safe has been on the market for more than 30 years and joined DSM's cheese cultures portfolio of Christian Hemmer, business manager of cheese at DSM, said: “The expansion of our high-quality cultures The easy-to-use cultures – combined with DSM’s end-to-end expertise and “one-stop-shop” portfolio of

Dutch ingredients start-up Vivici has launched Vivitein LF in the US, introducing a precision-fermented version of lactoferrin that aims to address longstanding supply and cost constraints around one of dairy’s most prized functional proteins. Lactoferrin, a bioactive whey fraction associated with immune modulation, iron absorption and gut barrier support, is typically extracted in small quantities from milk, making it scarce and expensive. As a result, its use has largely been confined to premium infant formula and specialist medical nutrition. Vivici’s approach uses precision fermentation to produce lactoferrin without animal inputs, enabling higher purity and potentially a more predictable supply. The ingredient has achieved self-affirmed GRAS status in the US, clearing a key commercial hurdle and allowing food, beverage and supplement manufacturers to incorporate it into finished products. The move comes as demand accelerates across the $938 billion global health and wellness foods market, projected to exceed $2.2 trillion by 2032. Energy, gut health and immune resilience remain priority claims for consumers, creating expansion potential for lactoferrin beyond early-life nutrition into women’s health, active recovery and functional beverages. Vivitein LF is the second product under Vivici’s Vivitein platform, following beta-lactoglobulin (BLG), and signals a broader strategy to build a portfolio of high-value dairy proteins via fermentation. Backed by established dairy and nutrition players, the company is expanding its manufacturing footprint to support global scale-up. For ingredient buyers, the key question will be whether fermentation-derived lactoferrin can reach price points that unlock mainstream applications, potentially reshaping sourcing strategies in categories where supply security and clinical substantiation are critical competitive levers.

DSM and Firmenich have entered into a merger agreement to become a leading supplier of nutrition, beauty The new company, called DSM-Firmenich, will bring together DSM's Food & Beverage and Firmenich's Taste DSM-Firmenich will help to further accelerate innovation and generate new growth opportunities for customers In total, DSM shareholders will own 65.5% of DSM-Firmenich, while Firmenich's shareholders will own the They continued: "Together DSM-Firmenich will enjoy complementary capabilities, including one of the largest

Firmenich and DSM have launched an exchange offer as part of their merger process, which was first announced Firmenich shareholders have already approved the transactions, while the DSM board has recommended its as we look to bring together DSM and Firmenich’s complementary capabilities, likeminded and passionate They added: “DSM-Firmenich is set to become the leading creation and innovation partner in nutrition, DSM-Firmenich will be a global-scale partner, uniquely positioned to anticipate and better address the

Royal DSM has launched new cheese culture Delvo Cheese CH-120, a range of phage robust cultures for young cheese producers’ needs in mind,” commented Evandro Oliveira de Souza, business lead for Cheese at DSM

FoodBev’s Dan Bunt spoke to Melanie Luangrath, director of new business development at DSM, following The winning innovation was DSM-Firmenich's Vertis CanolaPRO nutrition bar with cranberry. Whether it's powering Team DSM-Firmenich endurance cyclists, casual gym goers or just busy days, a high-quality

A similar focus on receptor science can be seen at DSM-Firmenich. Karel Stoschek, executive VP of Taste at the company, explained that DSM-Firmenich’s receptor-based discovery One commercial application of this receptor-led approach is DSM-Firmenich’s ModulaSense range. Stoschek stated that DSM-Firmenich combines flavour creation, sensory science, ingredient functionality